除了作为神经内科专业知识的杰出科学家外，埃里克是一名企业家，现在已经开发了现在的FDA批准过程的各个阶段的重要药物，并启动了毒品公司（Reveragen，Biopharma和Agada Biosciences）-isCEO of one, as well as being Associate Dean for Research at Binghamton University’s new School of Pharmacy and Pharmaceutical Sciences. Eric is an important member of Cornell's Taskforce on Plants and Medicinal Science for students interested in both plants and various aspects of human health—one that would provide alternative entry into the health professions.
